Stockreport

Natera Announces Enrollment of First Patients in SAGITTARIUS: a Randomized, Phase III Clinical Trial in Colon Cancer [Yahoo! Finance]

Natera, Inc.  (NTRA) 
Last natera, inc. earnings: 2/26 04:10 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.natera.com
PDF Approximately 700-900 patients expected to be enrolled across more than 20 sites AUSTIN, Texas, December 12, 2024 BUSINESS WIRE Natera, Inc. (NASDAQ: NTRA), a global [Read more]